Found 40 results
Author Title [ Type(Desc)] Year
Filters: Author is Wolff, M  [Clear All Filters]
Journal Article
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., Tartaglia, J., and Group, theN. I. A. I. D. A. I. D. S., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with Rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers, J Infec Dis, vol. 180, pp. 290-8, 1999.
T. G. Evans, Keefer, M. C., Weinhold, K. J., Wolff, M., Montefiori, D., Gorse, G. J., Graham, B. S., McElrath, M. J., Clements-Mann, M. L., Mulligan, M. J., Fast, P., Walker, M. C., Excler, J. L., Duliege, A. M., and Tartaglia, J., A canarypox vaccine expressing multiple human immunodeficiency virus type 1 genes given alone or with rgp120 elicits broad and durable CD8+ cytotoxic T lymphocyte responses in seronegative volunteers., J Infect Dis, vol. 180, no. 2, pp. 290-8, 1999.
M. Wolff, Moulton, L. H., Newcomer, W., Reid, R., and Santo, S. M., A case-control-study of risk factors for homophiles influenza Type B disease in Navajo children, AM J Trop Med Hug, vol. 60, pp. 263-6, 1999.
K. L. Kotloff, Halasa, N. B., Harrison, C. J., Englund, J. A., Walter, E. B., King, J. C., Creech, C. B., Healy, S. A., Dolor, R. J., Stephens, I., Edwards, K. M., Noah, D. L., Hill, H., and Wolff, M., Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children, Pediatr Infect Dis J, vol. 33, pp. 865-871, 2014.
R. W. Frenck, Jr, Belshe, R., Brady, R. C., Winokur, P. L., Campbell, J. D., Treanor, J., Hay, C. M., Dekker, C. L., Walter, Jr., E. B., TR, C., KM, E., Hill, H., Wolff, M., Leduc, T., and Tornieporth, N., Comparison of the Immunogenicity and Safety of a Split-Virion, Inactivated, Trivalent Influenza Vaccine (Fluzone®) Administered by Intradermal and Intramuscular Route in Healthy Adults, Vaccine, vol. 29, pp. 5666-5674, 2011.
J. C. King, Treanor, J., Fast, P. E., Wolff, M., Yan, L., Iacuzio, D., Readmond, B., O'Brien, D., Mallon, K., Highsmith, W. E., Lambert, J. S., and Belshe, R. B., Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults., J Infect Dis, vol. 181, no. 2, pp. 725-8, 2000.
B. R. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Cho, I., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine, J Infec Dis, vol. 181, pp. 11133-7, 2000.
R. B. Belshe, Gruber, W. C., Mendelman, P. M., Mehta, H. B., Mahmood, K., Reisinger, K., Treanor, J., Zangwill, K., Hayden, F. G., Bernstein, D. I., Kotloff, K., King, J., Piedra, P. A., Block, S. L., Yan, L., and Wolff, M., Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine., J Infect Dis, vol. 181, no. 3, pp. 1133-7, 2000.
R. B. Sack, Santosham, M., Reid, R., Black, R., Croll, J., Yolken, R., Aurelian, L., Wolff, M., Chan, E., and Garrett, S., Diarrhoeal diseases in the White Mountain Apaches: clinical studies., J Diarrhoeal Dis Res, vol. 13, no. 1, pp. 12-7, 1995.
M. Santosham, Sack, R. B., Reid, R., Black, R., Croll, J., Yolken, R., Aurelian, L., Wolff, M., Chan, E., and Garrett, S., Diarrhoeal diseases in the White Mountain Apaches: epidemiologic studies., J Diarrhoeal Dis Res, vol. 13, no. 1, pp. 18-28, 1995.
M. Laassri, Lottenbach, K., Belshe, R., Wolff, M., Rennels, M., Plotkin, S., and Chumakov, K., Effect of Different Vaccination Schedules on Excretion of Oral Poliovirus Vaccine Strains, J Infect Dis, vol. 192, pp. 2092-2098, 2005.
R. B. Belshe, Mendelman, P. M., Treanor, J., King, J., Gruber, W. C., Piedra, P., Bernstein, D. I., Hayden, F. G., Kotloff, K., Zangwill, K., Iacuzio, D., and Wolff, M., The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children., N Engl J Med, vol. 338, no. 20, pp. 1405-12, 1998.
R. B. Belshe, Gruber, W. C., Mendelman, P. M., Cho, I., Reisinger, K., Block, S. L., Wittes, J., Iacuzio, D., Piedra, P., Treanor, J., King, J., Kotloff, K., Bernstein, D. I., Hayden, F. G., Zangwill, K., Yan, L., and Wolff, M., Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine., J Pediatr, vol. 136, no. 2, pp. 168-75, 2000.
I. M. Longini, Halloran, M. E., Nizam, A., Wolff, M., Mendelman, P. M., Fast, P. E., and Belshe, R. B., Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control., Vaccine, vol. 18, no. 18, pp. 1902-9, 2000.
J. Treanor, Keitel, W., Belshe, R., Campbell, J., Schiff, G., Zangwill, K., Wolff, M., Klimov, A., Levandowski, R., and Lambert, L., Evaluation of a Single Dose of Half Strength Inactivated Influenza Vaccine in Healthy Adults, Vaccine, vol. 20, pp. 1099-1105, 2002.
L. R. Baden, ,, Seaman, M. S., Johnson, J. A., Tucker, R. P., Kleinjan, J. A., Gothing, J. A., Engelson, B. A., Carey, B. R., Oza, A., Bajimaya, S., Peter, L., Bleckwehl, C., Abbink, P., Pau, M. G., Weijtens, M., Kunchai, M., Swann, E. M., Wolff, M., Dolin, R., and Barouch, D. H., First-in-Human Evaluation of a Hexon Chimeric Adenovirus Vector Expressing HIV-1 Env (IPCAVD 002), J Infect Dis, vol. 210, pp. 1052-1061, 2014.
L. R. Baden, ,, Seaman, M. S., Tucker, R. P., Krause, K. H., Patel, A., Johnson, J. A., Kleinjan, J., Yanosick, K. E., Perry, J., Zablowsky, E., Abbink, P., Peter, L., Iampietro, M. J., Cheung, A., Pau, M. G., Weijtens, M., Goudsmit, J., Swann, E., Wolff, M., Loblein, H., and Dolin, R., First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001), J Infect Dis, vol. 207, pp. 240-247, 2013.
P. C. Rowe, Calkins, H., DeBusk, K., McKenzie, R., Anand, R., Sharma, G., Cuccherini, B. A., Soto, N., Hohman, P., Snader, S., Lucas, K. E., Wolff, M., and Straus, S. E., Fludrocortisone acetate to treat neurally mediated hypotension in chronic fatigue syndrome: a randomized controlled trial., JAMA, vol. 285, no. 1, pp. 52-9, 2001.
C. Duggan, Refat, M., Hashem, M., Wolff, M., Fayad, I., and Santosham, M., How valid are clinical signs of dehydration in infants?, J Pediatr Gastroenterol Nutr, vol. 22, no. 1, pp. 56-61, 1996.
N. A. Goji, Nolan, C., Hill, H., Wolff, M., Noah, D. L., Williams, T. B., Rowe, T., and Treanor, J. J., Immune Responses of Healthy Subjects to a Single Dose of Intramuscular Inactivated Influenza A/Vietnam/1203/2004 (H5N1) Vaccine After Priming with an Antigenic Variant, J Infec Dis, vol. 198, pp. 635-641, 2008.
L. A. Jackson, Patel, S. M., Swamy, G. K., Frey, S. E., Creech, C. B., Munoz, F. M., Artal, R., Keitel, W. A., Noah, D. L., Petrie, C. R., Wolff, M., and Edwards, K. M., Immunogenicity of an Inactivated Monovalent 2009 H1N1 Influenza Vaccine in Pregnant Women, J Infect Dis, vol. 204, pp. 854-863, 2011.
S. T. Callahan, Wolff, M., Hill, H. R., Edwards, K. M., Vaccine, N. I. A. I. D., and Group, T. Evaluation, Impact of Body Mass Index on Immunogenicity of Pandemic H1N1 Vaccine in Children and Adults, J Infect Dis, vol. 210, pp. 1270-1274, 2014.
L. Baden, Liu, J., Li, H., Johnson, J., Walsh, S., Kleinjan, J., Engelson, B., Peter, L., Abbink, P., ,, Golden, K., Viani, K., Stachler, M., Chen, B., ,, Wolff, M., Loblein, H., Seaman, M., Dolin, R., and Barouch, D., Induction of HIV-1-Specific Mucosal Immune Responses Following Intramuscular Recombinant Adenovirus Serotype 26 HIV-1 Vaccination of Humans, J Infect Dis, vol. 211, pp. 518-528, 2015.
P. B. Gilbert, Chiu, Y. - L., Allen, M., Lawrence, D. N., Chapdu, C., Israel, H., Holman, D., Keefer, M. C., Wolff, M., and Frey, S. E., Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials., Vaccine, vol. 21, no. 21-22, pp. 2933-47, 2003.
P. B. Gilbert, Chiu, Y. L., Allen, M., Lawrence, D. N., Chapdu, C., Israel, H., Holman, D., Keefer, M. C., Wolff, M., Frey, S. E., and Network, N. I. A. I. D. H. I. V. Vaccin, Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials, Vaccine, vol. 21-22, pp. 2933-2947, 2003.